Brian Peter Zambrowicz
Director/Miembro de la Junta en Texas A&M Institute for Genomic Medicine .
Cargos activos de Brian Peter Zambrowicz
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Texas A&M Institute for Genomic Medicine
 Texas A&M Institute for Genomic Medicine Miscellaneous Commercial ServicesCommercial Services Texas A&M Institute for Genomic Medicine focuses in research and development for medical industry. It was founded in 2006 and is headquartered in College Station, Texas. | Director/Miembro de la Junta | - | - |
Historial de carrera de Brian Peter Zambrowicz
Antiguos cargos conocidos de Brian Peter Zambrowicz.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/09/1995 | 24/02/2015 |
| Fundador | 07/07/1995 | 24/02/2015 | |
| NUEVOLUTION AB (PUBL) | Director/Miembro de la Junta | - | - |
| Corporate Officer/Principal | - | - |
Formación de Brian Peter Zambrowicz.
| University of Washington | Doctorate Degree |
| University of Wisconsin | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Dinamarca | 2 |
Operativa
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Nuevolution AB
 Nuevolution AB Pharmaceuticals: MajorHealth Technology Nuevolution AB engages in pharmaceutical and biotechnology discovery. Its activities include research and development, and licensing drugs and treatment of oncology and chronic inflammatory diseases including cancer. It offers the platform Chemetics, which enables discovery of small molecule drug candidates for specific indications addressing target diseases. The company was founded by Henrik Pedersen, Alex Haahr Gouliaev, and Mads Nørregaard-Madsen in May 2001 and is headquartered in Copenhagen, Denmark. | Health Technology |
Texas A&M Institute for Genomic Medicine
Texas A&M Institute for Genomic Medicine Miscellaneous Commercial ServicesCommercial Services Texas A&M Institute for Genomic Medicine focuses in research and development for medical industry. It was founded in 2006 and is headquartered in College Station, Texas. | Commercial Services |
